scholarly journals Evaluation of fructosamine concentration as an index marker for glycaemic control in diabetic dogs

2021 ◽  
Author(s):  
Florian K. Zeugswetter ◽  
Raphael Beer ◽  
Ilse Schwendenwein
Author(s):  
Eliana Teshima ◽  
Marcio Antonio Brunetto ◽  
Fabio Alves Teixeira ◽  
Márcia de Oliveira Sampaio Gomes ◽  
Silvia Regina Ricci Lucas ◽  
...  

Diabetologia ◽  
1990 ◽  
Vol 33 (9) ◽  
pp. 522-525 ◽  
Author(s):  
T. S. Kern ◽  
R. L. Engerman

1981 ◽  
Vol 19 (4) ◽  
pp. 406-410 ◽  
Author(s):  
A. Bahoric ◽  
A. M. Albisser ◽  
Y. Goriya ◽  
E. B. Marliss ◽  
B. Zinman

2018 ◽  
Vol 120 (7) ◽  
pp. 777-786 ◽  
Author(s):  
Fabio A. Teixeira ◽  
Daniela P. Machado ◽  
Juliana T. Jeremias ◽  
Mariana R. Queiroz ◽  
Cristiana F. F. Pontieri ◽  
...  

AbstractThe source of starch may interfere with glycaemic control in dogs, but few studies have evaluated these aspects in diabetic dogs. This study compared the effects of two isonutrient diets with different starch sources, peas and barley (PB) v. maize (Mi), on diabetic dogs. The Mi diet was processed in order to generate a lower starch gelatinisation index. In all, fifteen adult diabetic dogs without other conditions were included. The animals were fed two dry extruded rations with moderate levels of fat and starch and high levels of protein and fibre using a random, double-blind cross-over design. Glycaemic curves over 48 h were developed via continuous glucose monitoring after 60 d on each diet and with the same neutral protamine Hagedorn (NPH) insulin dosage. The following were compared: fasting, mean, maximum and minimum blood glucose, maximum and minimum glycaemia difference, glycaemic increment, area under the glycaemic curve, area under the glycaemic increment curve and serum fructosamine concentration. Paired t tests or Wilcoxon signed-rank tests were used to compare the amount of food and nutrients ingested and the dietary effects on glycaemic variables between the diets. Dogs fed the PB diet presented a lower average mean interstitial glucose (P=0·01), longer mean hypoglycaemic time (P<0·01), shorter mean hyperglycaemic time (P<0·01) and smaller difference between maximum and minimum blood glucose levels (P=0·03). Thus, the processing applied to the Mi diet was not sufficient to achieve the same effects of PB on glycaemic control in diabetic dogs.


2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
M Ziemen ◽  
RM Bergenstal ◽  
MC Riddle ◽  
M Rojeski ◽  
M Espinasse ◽  
...  

2013 ◽  
Vol 3 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Zafar Ahmed Latif ◽  
Md. Faruque Pathan ◽  
Md. Nazrul Islam Siddiqui ◽  
MA Mannan ◽  
SM Ashrafuzzaman ◽  
...  

Objective: To present results from the Bangladesh cohort of the A1chieve study receiving insulin detemir (Levemir) ± oral anti diabetic drugs. Methods: Out of 1093 patients recruited from 49 sites in Bangladesh, 370 were initiated on insulin detemir (Levemir).Study visits were defined as baseline, interim (around 12 weeks from baseline) and final (around 24 weeks from baseline) visit. Results: Glycaemic control was poor in all the groups at baseline. In the entire cohort at 24 weeks, significant reductions from baseline were observed in mean HbA1c (from 10.0 % to 7.2%, p<0.001), FPG (from 10.5 to 6.7 mmol/L, p<0.001) and PPPG (from 15.3 to 8.9 mmol/L, p<0.001) levels. Overall 45.5% of the participants achieved target HbA1c level of < 7% after 24 weeks. The rate of all hypoglycaemic events in the entire cohort reduced from 1.34 (baseline) to 0.12 events/person year after 24 weeks of insulin detemir therapy (p<0.0001). There was no clinically relevant change in body weight in insulin naïve or prior insulin users groups after 24 weeks of insulin detemir therapy. Conclusions: The current study suggests that insulin detemir may be considered as a safe and effective option for initiating insulin therapy for type 2 diabetes in Bangladesh. Birdem Med J 2013; 3(1): 11-18 DOI: http://dx.doi.org/10.3329/birdem.v3i1.17121


Sign in / Sign up

Export Citation Format

Share Document